Sirolimus-eluting vs. paclitaxel-eluting stents in diabetic and non-diabetic patients with in "LIMUS"-stent restennosis, results from the ISAR DESIRE 2 trial | Zendy

AI Assistant Blog Pricing

Sirolimus-eluting vs. paclitaxel-eluting stents in diabetic and non-diabetic patients with in "LIMUS"-stent restennosis, results from the ISAR DESIRE 2 trial

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.